InsiderClue
← All stocks

Alto Neuroscience, Inc.

ANRO Net buying
CIK 0001999480 #2333 in the set updated 22 Sep 2026
Bought (120 mo)
$10.24M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$10.24M
+$10.24M against sales at will

By person

8 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Alpha Wave Global, LP entity
10% owner
$9.60M (1)
—
+$9.60M
3,707,757
9.45%
$49.02M
—
Savitz Adam
CHIEF MEDICAL OFFICER
$462.83K (4)
—
+$462.83K
39,851
0.1016%
$526.83K
—
Smith Nicholas Conrad
CHIEF FINANCIAL OFFICER & CBO
$125.64K (3)
—
+$125.64K
24,060
0.0613%
$318.07K
—
Etkin Amit
PRESIDENT AND CEO
$50.00K (1)
—
+$50.00K
833,949
2.13%
$11.02M
−30.0%
Apeiron Investment Group Ltd. entity
See Remarks
—
—
—
926,539
2.36%
$12.25M
—
Cox Christopher Nixon
Director
—
—
—
715,653
1.82%
$9.46M
—
Chen Po Yu (Jeff)
Director
—
—
—
47,709
0.1216%
$630.71K
—
York Gwill
Director
—
—
—
23,917
0.0609%
$316.18K
—

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Savitz Adam
10 Jul 2024
CHIEF MEDICAL OFFICER
Buy indirect
2,931
$13.22
$38.75K
Savitz Adam
9 Jul 2024
CHIEF MEDICAL OFFICER
Buy indirect
1,388
$13.15
$18.25K
Savitz Adam
9 Jul 2024
CHIEF MEDICAL OFFICER
Buy indirect
10,681
$12.53
$133.83K
Smith Nicholas Conrad
28 Mar 2024
CHIEF FINANCIAL OFFICER
Buy
4,550
$16.56
$75.35K
Smith Nicholas Conrad
28 Mar 2024
CHIEF FINANCIAL OFFICER
Buy
1,600
$15.80
$25.28K
Etkin Amit
6 Feb 2024
PRESIDENT AND CEO
Buy
3,125
$16.00
$50.00K
Savitz Adam
6 Feb 2024
CHIEF MEDICAL OFFICER
Buy indirect
17,000
$16.00
$272.00K
Smith Nicholas Conrad
6 Feb 2024
CHIEF FINANCIAL OFFICER
Buy
1,563
$16.00
$25.01K
Alpha Wave Global, LP
6 Feb 2024
10% owner
Buy indirect
600,000
$16.00
$9.60M

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 5,304,100
History held since 5 Feb 2024